Dr. Rakesh K. Srivastava

Dr. Rakesh K. Srivastava is an accomplished entrepreneur and is the CEO and President of GLAX Health LLC.

WILMINGTON, DELAWARE, UNITED STATES, August 30, 2022

— Dr. Rakesh K. Srivastava’s Inhibition of the Shh Pathway to Treat Alzheimer’s And Cancer

Imagine waking up one day unable to remember where you are or the loved ones around you. This is the reality that most Alzheimer's patients face. Alzheimer's is characterized by memory loss and confusion. Patients suffering from this condition also have difficulty communicating effectively, completing mundane chores, and handling their finances and could easily get lost. Patients with Alzheimer's need constant, round-the-clock care, which is pretty taxing on their family members. On the other hand, cancer is a condition characterized by the rapid division of abnormal cells that could destroy healthy body tissues. Keep reading this article to learn more about these two conditions and the new drug Dr. Rakesh Srivastava discovered to treat them.

What is the Shh pathway?

The sonic hedgehog pathway, also known as Shh, is a trafficking network that facilitates the movement of information to embryonic cells. This pathway got its name when a postdoc working at Cliff Tabin’s lab drew inspiration from a comic book his daughter used to read. Dr. Rakesh K. Srivastava discovered that the Shh pathway in cancer patients depicted an overexpression of specific components such as Gli, Ptch-1, and SMO.

The development of a new drug to treat AD and cancer

GLAX Health and a team of scientists from the Indian Institute of Technology combined forces and developed a drug that simultaneously targets AD and cancer. This drug inhibits the expression of the SMO receptor in the pathway. This drug could also destroy cancer stem cells that cause cancer initiation and progression, not to mention drug resistance. With time, GLAX LLC received a US patent for this new drug and would soon begin to obtain patients to treat.

According to Dr. Srivastava, an inactive Shh pathway could mean the patient will benefit more from chemotherapy, experience increased radio sensitivity, and guarantee reduced cancer risk. Targeted therapies using the drug Dr. Srivastava developed are a much better alternative to traditional chemotherapy as it comes with fewer side effects and poses a better chance of survival.

How to reduce your risk of developing AD and cancer

First and foremost, Dr. Rakesh Srivastava urges everyone to lead a healthy lifestyle by eating nutritious food and incorporating physical activity in their daily routine. It would also help to reduce your alcohol consumption and avoid smoking at all costs. Unfortunately, if you have already started smoking, we suggest you take the necessary measures to quit. Since you cannot control or slow down the aging process, it would help to focus on what you can control, such as making healthy choices before it is too late.

At least six million Americans have Alzheimer's today. Unfortunately, this condition has no cure, and scientists expect this number to rise. Dr. Rakesh Srivastava is confident that his research has paid off, and this new drug will help bring those devastating numbers down and alleviate patients' suffering. The development of this new drug brings Dr. Srivastava and his team one step closer to eliminating diseases from the face of the earth.

Contact: Dr. Rakesh Srivastava
www.rksrivastava.com
Email: contact@glaxhealth.com

Rakesh Srivastava
GLAX, LLC.